Trials / Completed
CompletedNCT00379067
A Phase 4 Study With Tamsulosin OCAS to Assess Nighttime Voiding.
A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Tamsulosin OCAS 0.4 mg Tablets, Once Daily on Nocturia, Compared to Placebo, in Patients With Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 882 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- Male
- Age
- 45 Years
- Healthy volunteers
- Not accepted
Summary
Randomized, double-blind, placebo-controlled study with two treatment arms (Tamsulosin OCAS 0.4 mg \& placebo). The study comprises a 2-week placebo run-in followed by a 12-week treatment period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tamsulosin OCAS | Adrenoceptor antagonist |
| DRUG | Placebo | placebo |
Timeline
- Start date
- 2005-10-01
- Primary completion
- 2006-11-01
- Completion
- 2006-11-01
- First posted
- 2006-09-21
- Last updated
- 2014-10-10
Source: ClinicalTrials.gov record NCT00379067. Inclusion in this directory is not an endorsement.